通过破坏线粒体通路,PSMF1变体导致从早期发病的帕金森病到围产期死亡的表型谱
Francesca Magrinelli1, Christelle Tesson2, Plamena R Angelova1
1Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
medRxiv : the preprint server for health sciences
|August 16, 2024
概括
PSMF1基因中的遗传变异与早期发病的帕金森氏症有关.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 门德尔基因的发现对于了解帕金森病 (PD) 病原体至关重要.
- 识别参与神经退行的基因有助于发现生物标志物和治疗点.
研究的目的:
- 识别与帕金森病和儿童神经退行相关的新基因.
- 研究PSMF1.1中遗传变异的功能后果.
主要方法:
- 对15个不相关的血统进行了基因分析,这些血统中出现了早期发病的PD和神经退行.
- 使用患者衍生的纤维细胞来评估线粒体功能的功能研究.
- 对于PSMF1缺乏症的Drosophila和小鼠模型的开发.
主要成果:
- 双性PSMF1变体与早期发病的PD,帕金森症和围产死亡率共同分离.
- 在患者细胞中,PSMF1变异会损害线粒体膜潜力,动力学和线粒体细胞衰变.
- 在PSMF1的淘汰赛/淘汰赛模型中,运动缺陷和结症是常见的.
结论:
- 在PSMF1的缺陷是明确地与早期发病的PD和神经退行有关.
- 线粒体功能障碍是PSMF1相关的神经退行的一个关键机制贡献者.
相关概念视频
Parkinson's Disease: Overview
501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501
Parkinson's Disease: Treatment
240
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
ATP Synthase: Mechanism
14.2K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.2K


